A detailed history of Mackenzie Financial Corp transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 922,056 shares of TMO stock, worth $484 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
922,056
Previous 550,859 67.39%
Holding current value
$484 Million
Previous $305 Million 87.22%
% of portfolio
0.85%
Previous 0.48%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$531.86 - $624.21 $197 Million - $232 Million
371,197 Added 67.39%
922,056 $570 Million
Q2 2024

Aug 14, 2024

SELL
$541.52 - $599.02 $35.2 Million - $39 Million
-65,075 Reduced 10.57%
550,859 $305 Million
Q1 2024

May 10, 2024

BUY
$528.82 - $599.43 $1.06 Million - $1.2 Million
2,004 Added 0.33%
615,934 $358 Million
Q4 2023

Jan 30, 2024

SELL
$431.41 - $532.94 $260 Million - $321 Million
-602,973 Reduced 49.55%
613,930 $326 Million
Q3 2023

Oct 25, 2023

SELL
$498.29 - $574.41 $26.6 Million - $30.7 Million
-53,424 Reduced 4.21%
1,216,903 $616 Million
Q2 2023

Aug 03, 2023

BUY
$508.46 - $591.13 $142 Million - $166 Million
280,008 Added 28.27%
1,270,327 $663 Million
Q1 2023

Apr 24, 2023

BUY
$535.0 - $604.82 $30.1 Million - $34.1 Million
56,336 Added 6.03%
990,319 $571 Million
Q4 2022

Feb 14, 2023

BUY
$484.71 - $571.37 $10.1 Million - $11.9 Million
20,901 Added 2.29%
933,983 $514 Million
Q3 2022

Oct 07, 2022

BUY
$507.19 - $604.49 $85.7 Million - $102 Million
168,919 Added 22.7%
913,082 $463 Million
Q2 2022

Aug 10, 2022

BUY
$500.9 - $612.21 $6.99 Million - $8.54 Million
13,954 Added 1.91%
744,163 $404 Million
Q1 2022

May 13, 2022

BUY
$524.0 - $644.92 $51.9 Million - $63.9 Million
99,052 Added 15.69%
730,209 $431 Million
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $74.4 Million - $87.2 Million
-130,695 Reduced 17.15%
631,157 $421 Million
Q3 2021

Nov 08, 2021

BUY
$509.53 - $609.78 $16.3 Million - $19.5 Million
32,040 Added 4.39%
761,852 $435 Million
Q2 2021

Aug 11, 2021

SELL
$441.0 - $508.24 $94.1 Million - $108 Million
-213,324 Reduced 22.62%
729,812 $368 Million
Q1 2021

May 14, 2021

BUY
$439.85 - $518.83 $277 Million - $327 Million
629,471 Added 200.68%
943,136 $430 Million
Q4 2020

Feb 10, 2021

SELL
$435.06 - $527.66 $15.2 Million - $18.5 Million
-34,970 Reduced 10.03%
313,665 $146 Million
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $22.9 Million - $28.1 Million
-63,545 Reduced 15.42%
348,635 $154 Million
Q2 2020

Aug 13, 2020

BUY
$275.2 - $362.34 $7.21 Million - $9.5 Million
26,214 Added 6.79%
412,180 $149 Million
Q1 2020

May 14, 2020

SELL
$255.3 - $340.05 $121 Million - $162 Million
-475,675 Reduced 55.21%
385,966 $109 Million
Q4 2019

Feb 13, 2020

BUY
$271.93 - $328.04 $61.5 Million - $74.2 Million
226,320 Added 35.62%
861,641 $280 Million
Q3 2019

Nov 14, 2019

BUY
$268.46 - $305.43 $167 Million - $191 Million
623,859 Added 5442.85%
635,321 $185 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $1.16 Million - $1.33 Million
-4,516 Reduced 28.26%
11,462 $3.37 Million
Q1 2019

May 15, 2019

BUY
$212.17 - $273.72 $611,261 - $788,587
2,881 Added 22.0%
15,978 $4.37 Million
Q4 2018

Feb 06, 2019

SELL
$208.47 - $251.98 $316,248 - $382,253
-1,517 Reduced 10.38%
13,097 $2.93 Million
Q3 2018

Nov 15, 2018

SELL
$205.57 - $244.32 $178,434 - $212,069
-868 Reduced 5.61%
14,614 $3.57 Million
Q2 2018

Aug 13, 2018

BUY
$203.14 - $219.53 $85,115 - $91,983
419 Added 2.78%
15,482 $3.21 Million
Q1 2018

May 14, 2018

BUY
$192.98 - $224.11 $1.94 Million - $2.26 Million
10,078 Added 202.17%
15,063 $3.11 Million
Q4 2017

Feb 13, 2018

BUY
$182.03 - $200.37 $11,831 - $13,024
65 Added 1.32%
4,985 $947,000
Q2 2017

Aug 14, 2017

BUY
N/A
4,920
4,920 $858,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $206B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.